M&A Deal Summary

Solar Biotech Acquires Noblegen

On July 25, 2023, Solar Biotech acquired life science company Noblegen

Acquisition Highlights
  • This is Solar Biotech’s 1st transaction in the Life Science sector.
  • This is Solar Biotech’s 1st transaction in Canada.
  • This is Solar Biotech’s 1st transaction in Ontario.

M&A Deal Summary
Date 2023-07-25
Target Noblegen
Sector Life Science
Buyer(s) Solar Biotech
Deal Type Add-on Acquisition

Target

Noblegen

Peterborough, Ontario, Canada
Noblegen is an advanced digital biology company that employs microorganisms to reshape the world’s linear food systems with efficient and affordable circular solutions. In its first phase of commercialization, the company has reinvented the world’s approach to food & agriculture. Its next phases of commercialization include biomaterials, health, energy, and space, among other industries. Noblegen was formed in 2013 and is based in Peterborough, Ontario.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Solar Biotech

Norton, Virginia, United States
Category Company
Sector Life Science
DESCRIPTION

Solar Biotech is a SynBio product and advanced bioprocessing technology development company with a mission to transform the way consumer products are manufactured via advanced bioprocessing technologies, including precision fermentation. The research and development and biomanufacturing facility in Norton, Virginia, has facilitated over the past years the successful introduction of several major products to the SynBio food and beverage and other market segments. Solar Biotech is based in Norton, Virginia.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2023) 1 of 1
Mergr

Product

Company

Legal